BILLS-113hr2285ih.pdf

2013 15 2010 annually 1 year 2 years fiscal years 2014 through 2018 September 3 years 2012 12 months each year September 30, 2006 2005 JUNE 6, 2013 later than 2 years more than a decade 1918 later than 1 year 2009 2001 1ST SESSION H. R. 2285 each of fiscal years 2014 through 2020 VerDate Mar

the ‘‘Strategies to Address

PO 00000 Frm 00012 PO 00000 Frm 00002 PO 00000 Frm 00019 PO 00000 Frm 00017 PO 00000 Frm 00010 PO 00000 Frm 00007 Resistance Task Force PO 00000 Frm 00025 PO 00000 Frm 00001

the United States United States Columbia the United States of America The United States Agency

United

SEC Antimicrobial Advisory Board the Antimicrobial Resistance Office Control and Prevention the Centers for Disease Office Federal Advisory Board Drug Administration State Health Antimicrobial Advisory Board Resistance Office the Public Health Service Act Centers for Disease Control and Prevention the Public Health Action Plan Senate the Centers for Disease Con- Disease Control and Prevention Resistance Surveillance Food and Drug Administration the Department of Defense the Public Health Action Energy and Commerce THE HOUSE OF REPRESENTATIVES the Department of Home- 7 the Antimicrobial Resistance 11 Office The Department of Agriculture the Federal Food Resistance Task Force Health House The Health Resources the National Institute of Allergy Centers for Disease Control -Udall Foundation Disease Control the Task Force Congress the Advisory Board The Food and Drug Administra- House of Representa- Quality Forum the Public Health Antimicrobial Advisory Board Task Force the Clinical Research Network The Department of Homeland

VerDate Mar Reagan MATHESON

antimicrobial resistance task force task advisory board drugs infectious force public health pwalker bills advisory act enhance bills pwalker pwalker mar jun